Comments

SAB Biotherapeutics

Q: What sector and industry does SAB Biotherapeutics (SABSW) operate in?

SAB Biotherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

SABSWNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$0.0900

-0.01-10.00%

At close: -

$0.1200

0.0333.33%

After Hours: Dec 20, 9:01 AM EDT

SAB Biotherapeutics (SABSW) Forecast

News Earnings SAB Biotherapeutics (SABSW) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

SAB Biotherapeutics (NASDAQ:SABSW) Stock Quotes, Forecast and News Summary

SAB Biotherapeutics Stock (NASDAQ: SABSW) stock price, news, charts, stock research, profile.

Open	$0.09
Close	$0.09
Volume / Avg.	11.64K / 22.45K
Day Range	$0.08 - $0.09
52 Wk Range	0.01 - 0.19
Market Cap	-
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	56
Short Interest	-
Days to Cover	1

Recent News

No news found

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Open	$0.09
Close	$0.09
Volume / Avg.	11.64K / 22.45K
Day Range	$0.08 - $0.09
52 Wk Range	0.01 - 0.19
Market Cap	-
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	56
Short Interest	-
Days to Cover	1

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy SAB Biotherapeutics (SABSW) stock?

You can purchase shares of SAB Biotherapeutics (NASDAQ:SABSW) through any online brokerage.

View our list of the best stock brokerages

Who are SAB Biotherapeutics (SABSW) competitors?

Other companies in SAB Biotherapeutics’s space includes: Sarepta Therapeutics (NASDAQ:SRPT), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX), Roivant Sciences (NASDAQ:ROIV) and Amgen (NASDAQ:AMGN).

What is the forecast, or price target, for SAB Biotherapeutics (SABSW) stock?

There is no analysis for SAB Biotherapeutics to provide a consensus price target.

What is the current price for SAB Biotherapeutics (SABSW)?

The stock price for SAB Biotherapeutics (NASDAQ: SABSW) is $0.09 last updated December 20, 2024 at 2:59 PM EST.

Does SAB Biotherapeutics (SABSW) pay a dividend?

There are no upcoming dividends for SAB Biotherapeutics.

When is SAB Biotherapeutics (NASDAQ:SABSW) reporting earnings?

SAB Biotherapeutics does not have any upcoming earnings scheduled.

Is SAB Biotherapeutics (SABSW) going to split?

There is no upcoming split for SAB Biotherapeutics.

What sector and industry does SAB Biotherapeutics (SABSW) operate in?

SAB Biotherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.